Indication
As monotherapy is indicated for the treatment of adult patients with progressing desmoid tumours (DT) who require systemic treatment.
Medicine details
- Medicine name:
- nirogacestat (Ogsiveo)
- SMC ID:
- SMC3021
- Pharmaceutical company
- Merck Serono Ltd
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC